CLEVELAND, Jan. 4, 2016 /PRNewswire/ – DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ technologies and delivering related services for the clinical trials industry, today announced that results from an internal client survey confirm that DATATRAK's customer-centric approach to clinical trial solutions has had a positive impact.
A satisfaction survey completed by DATATRAK's top clients demonstrates a high satisfaction rating for both DATATRAK's products and customer support. Reliability, usefulness, and overall value were a few of the high ranking aspects of the DATATRAK user experience. "I'm not surprised," indicated Laurence P. Birch, CEO of DATATRAK. "We've really focused our efforts on streamlining the entire customer experience from contract signing through fulfillment, and this is just further proof that our dedication and hard work is paying off for the customer. This approach has allowed us to build strong customer relationships, and is why almost all who took the survey say they would recommend us and our products to others."
"Our product has to be easy and intuitive for the customer to use to gain the maximum benefit," says Tim Lyons, Vice President, Product Development and Operations at DATATRAK. "The survey results show that the Unified Experience™ methodology we've applied to our software platform is really working for our customers. For example, the ease with which they can run any report they need with real-time results is a definite crowd pleaser and a factor that several customers specifically pointed out as being a highlight of our product. Moreover, that's just one of many aspects of the DATATRAK UX™ platform; customers have a satisfying clinical trial experience all around."
DATATRAK International, the leader in developing cloud-based, unified dClinical™ platform, is a worldwide technology and consulting company serving the clinical trials industry. The company delivers a portfolio of software solutions that safely accelerate clinical research, from Concept to Cure®.
Join DATATRAK Thought Leaders:
Tweet: Ease of use and great reporting give #DATATRAK clients a consistently great value for #clinicaltrials. Book a demo today. http://ow.ly/WD9SG
DATATRAK International is a worldwide technology and services company delivering Unified dClinical™ solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Chicago, IL; Cary Research Triangle Park (RTP), North Carolina; Bryan, Texas; and Cleveland, Ohio. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.